News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 13317
- Sources here
- 13
- Companies here
- 42
Active search
13317 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Tenaris (NYSE:TS) Cut to Hold at Wall Street Zen
Wall Street Zen downgraded Tenaris (NYSE:TS) from a "buy" to a "hold" rating. The broader analyst consensus for Tenaris is also "Hold," with an average price target of $63.28, despite the company exceeding quarterly expectations with adjusted EPS of $0.95 and revenue of $2.97 …
Safe Pro Group Inc. (SPAI): Citadel entities disclose 3.6% beneficial stake
Citadel-related entities and Kenneth Griffin have disclosed a 3.6% beneficial stake in Safe Pro Group Inc. (SPAI) through an amended Schedule 13G/A filing. This ownership includes 768,855 shares, with 750,000 shares issuable upon the conversion of warrants. The reporting persons collectively hold shared voting …
Telecom Argentina Stet - France Telecom (NYSE:TEO) Downgraded by Wall Street Zen to Hold
Wall Street Zen downgraded Telecom Argentina (NYSE:TEO) from "Buy" to "Hold," aligning with the overall analyst consensus. The company's shares opened at $13.34, and despite mixed analyst sentiment with some increasing price targets and a director purchasing shares, the average price target is $15.43. …
Price-Driven Insight from (TEN) for Rule-Based Strategy
This article provides a price-driven insight for Tsakos Energy Navigation Ltd (NYSE: TEN) with a focus on rule-based trading strategies. It highlights near-term strong sentiment, potential mid-term neutrality, and long-term positive bias, along with resistance and support levels. The analysis offers specific institutional trading …
ADC Therapeutics (NYSE:ADCT) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded ADC Therapeutics (NYSE:ADCT) from a "sell" to a "hold" rating. The company reported a quarterly loss of $0.11 per share, beating analyst estimates, with revenue of $19.25 million also exceeding expectations. Despite mixed analyst coverage, the stock has a consensus …
Maxim Group Maintains Palisade Bio(PALI.US) With Buy Rating, Maintains Target Price $8
Maxim Group has reiterated its Buy rating for Palisade Bio (PALI.US) and maintained its target price at $8. This indicates continued confidence from the firm in the company's prospects.
Savara (NASDAQ:SVRA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded Savara (NASDAQ:SVRA) from a "hold" to a "sell" rating, despite a broader analyst consensus of "Moderate Buy" with a $10.14 price target. The company recently reported a quarterly loss of $0.16 per share, missing expectations, and analysts have lowered …
Intellicheck (NASDAQ:IDN) Downgraded to "Hold" Rating by Wall Street Zen
Wall Street Zen downgraded Intellicheck (NASDAQ:IDN) from "buy" to "hold," causing the stock to drop 25.1% to $2.81, near its 12-month low. Despite the downgrade and similar actions by other analysts, the consensus remains a "Moderate Buy" with an average target price of $6.50. …
Universal Logistics (NASDAQ:ULH) Upgraded to Buy at Wall Street Zen
Wall Street Zen has upgraded Universal Logistics (NASDAQ:ULH) from a "hold" to a "buy" rating, despite the broader analyst consensus remaining "sell" with a $15.00 price target. The company recently reported quarterly EPS of $0.16, surpassing estimates, though revenue slightly missed expectations. Institutional investors …
AerSale (NASDAQ:ASLE) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen has downgraded AerSale (NASDAQ:ASLE) from a "hold" to a "sell" rating. This follows other analyst reports, with B. Riley Financial setting a "neutral" rating, Royal Bank of Canada reducing its price target, and Zacks Research upgrading it to a "hold." The …
Murphy USA (MUSA) Is Up 9.4% After Dividend Hike And Strong Q2 Results - What's Changed
In early August 2026, Murphy USA reported second-quarter revenue of US$6,806.1 million and net income of US$209.1 million, alongside a quarterly dividend increase to US$0.65 per share, payable on September 3, 2026, to shareholders of record on August 24, 2026. This combination of higher …
Sharemaestro market context Trend signal active 52 weeks +35.0% · Next-week setup negative 37.9%Comfort Systems (FIX) Stock May Be 32% Undervalued As Cash Flow Holds Up
Comfort Systems USA (FIX) stock appears to be 32% undervalued based on a Discounted Cash Flow (DCF) analysis, despite a significant 5-year return. While the DCF model suggests a substantial discount to intrinsic value, its P/E ratio is close to the industry average, indicating …
Samsung Electronics (KOSE:A005930) Ends Memory Patent Fight With Five Year Licensing Deal
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Samsung Electronics (KOSE:A005930) and Netlist announced a comprehensive patent settlement and long-term alliance covering …
Tenaris S.A. Stock 12‑Month Price Target Raised to $64.99, Implies 21% Upside
Analysts have increased the average 12-month price target for Tenaris S.A. stock to $64.99 from $61.69, suggesting a potential 21% upside from its Aug. 14 closing price. The consensus rating for TEN has shifted to "Hold" among 14 covering analysts, with an even split …
Titan America SA Stock 12‑Month Price Target Raised to $19.4, Implies 21% Upside
The average 12-month price target for Titan America SA (TTAM) stock has been raised from $19.25 to $19.4 by 5 analysts, with a range of $17 to $22 per share. This new target implies a potential upside of approximately 21% from its Aug. 14 …
Kiniksa Pharmaceuticals International, plc Class A Revenue Breakdown – BIVA:KNSA/N
Kiniksa Pharmaceuticals International, plc (BIVA:KNSA/N) generated 12.21 billion MXN in revenue last year, primarily from its Therapeutic Medicines segment. The United States was the largest contributor to this revenue, accounting for 12.20 billion MXN. This represents an increase from the previous year's segment revenue …
Why Spotify (SPOT) Is Up 5.1% After Strong Q2 2026 Results and Capital Return Update
Spotify's stock (SPOT) rose 5.1% after reporting strong Q2 2026 results with €4.78 billion in revenue and €545 million in net income, and providing optimistic Q3 guidance. The company also completed a US$1.21 billion share repurchase program, demonstrating a balance between growth investments and …
Companhia De Saneamento Basico Do Estado De Sao (SBS) Q2 2026 Earnings Report - Results, Call & Slides
This article first appeared on GuruFocus. Adjusted Net Revenue: Grew 9.4% year over year, reflecting tariff adjustments and customer expansion. Adjusted EBITDA: Totaled BRL3.5 billion, down 2.3% year over year, with an EBITDA margin of 58.3%. Adjusted Net Income: Reached BRL1.2 billion, with the …
Woodline Partners (SABS) discloses 5.46M-share beneficial stake in SAB Biotherapeutics
Woodline Partners LP has filed an amended Schedule 13G, disclosing a beneficial ownership of 5,455,355 shares, or 6.8%, of SAB Biotherapeutics, Inc. common stock. This stake includes common shares and shares issuable from Series B Preferred Stock underlying Enrollment and Data Release Warrants. The …
Processa Pharmaceuticals 3Q 2026: Net loss $(3.27M), EPS $(1.19) — 10-Q Summary
Processa Pharmaceuticals (PCSA) reported a net loss of $(3.27M) and diluted EPS of $(1.19) for the third quarter of 2026, showing an improvement from the previous year, with no product revenue. The company recently acquired Vidya, securing $200M in funding to advance new clinical …